Russian producer of antimalarial medicines based on artemisinin seeks distributors and partners for joint venture agreements

The company from Novosibirsk was founded in 2019. The company specializes in the production of antimalarial medicines based on artemisinin. The company manufactures pharmaceutical components for antimalarial medicines including: • Artemisinin; • Artemisinin acid; • Artesunate; • Artemether; • Artemether + lumefantrine; • Artesunate + amodiaquine. Potential artemisinin-based drugs for the treatment of certain types of cancer. The company's products are manufactured according to GMP standards. The site produces medicines for the treatment of cancer patients and antibiotics used to treat COVID-19. Preparations for malaria are planned to be exported, as they do not suffer from it in Russia. However, antibiotics and anti-cancer drugs will be supplied both on the Russian and foreign markets. The company wants to expand it's business and collaboration with small, medium and big companies in the field of pharmaceutical products. The company is looking for a long term partnership under the joint venture agreement. The agreement presupposes the joint development and commercialization of research results. The company wants to expand abroad with growing production and therefore they wish to find new partners - distributors, capable to roll out the products on their markets, based on distribution agreements.